1. Bourekas EC, Varakis K, Bruns D, Christoforidis GA, Baujan M, Slone HW, Kehagias D (2002) Lesions of the corpus callosum: MR imaging and differential considerations in adults and children. AJR American journal of roentgenology 179: 251-257 doi:10.2214/ajr.179.1.1790251
2. Ho ML, Moonis G, Ginat DT, Eisenberg RL (2013) Lesions of the corpus callosum. AJR American journal of roentgenology 200: W1-16 doi:10.2214/ajr.11.8080
3. Chaichana KL, Jusue-Torres I, Lemos AM, Gokaslan A, Cabrera-Aldana EE, Ashary A, Olivi A, Quinones-Hinojosa A (2014) The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors? Journal of neuro-oncology 120: 625-634 doi:10.1007/s11060-014-1597-9
4. Dayani F, Young JS, Bonte A, Chang EF, Theodosopoulos P, McDermott MW, Berger MS, Aghi MK (2018) Safety and outcomes of resection of butterfly glioblastoma. 44: E4 doi:10.3171/2018.3.Focus1857
5. Dziurzynski K, Blas-Boria D, Suki D, Cahill DP, Prabhu SS, Puduvalli V, Levine N (2012) Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes. Journal of neuro-oncology 109: 555-563 doi:10.1007/s11060-012-0926-0
6. Burks JD, Bonney PA, Conner AK, Glenn CA, Briggs RG, Battiste JD, McCoy T, O'Donoghue DL, Wu DH, Sughrue ME (2016) A method for safely resecting anterior butterfly gliomas: the surgical anatomy of the default mode network and the relevance of its preservation. 126: 1795 doi:10.3171/2016.5.Jns153006
7. Hall BJ, Maleyko I, Brodbelt A, Jenkinson MD, Chavredakis E (2019) The utility of surgery in butterfly glioblastoma: A case-control study. Journal of Clinical Oncology 37: e13529-e13529 doi:10.1200/JCO.2019.37.15_suppl.e13529
8. Opoku-Darko M, Amuah JE, Kelly JJP (2018) Surgical Resection of Anterior and Posterior Butterfly Glioblastoma. World neurosurgery 110: e612-e620 doi:https://doi.org/10.1016/j.wneu.2017.11.059
9. Weller M, Bent M, Preusser M, Le Rhun E, Tonn J, Minniti G, Bendszus M, Balana C, Chinot O, Dirven L, French P, Hegi M, Jakola AS, Platten M, Roth P, Rudà R, Short S, Smits M, Taphoorn M, Deimling A, Westphal M, Soffietti R, Reifenberger G, Wick W (2020) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nature reviews Clinical oncology 18: 170-186 doi:10.1038/s41571-020-00447-z
10. Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F, Hallani SE, Boisselier B, Mokhtari K, Hoang-Xuan K, Delattre JY (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. Journal of Clinical Oncology 27: 4150-4154 doi:10.1200/JCO.2009.21.9832
11. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-oncology 23: 1231-1251 doi:10.1093/neuonc/noab106 %J Neuro-Oncology
12. Olson RA, Brastianos PK, Palma DA (2011) Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysis. Journal of neuro-oncology 105: 325-335 doi:10.1007/s11060-011-0594-5
13. Burger MC, Ronellenfitsch MW, Lorenz NI, Wagner M, Voss M, Capper D, Tzaridis T, Herrlinger U, Steinbach JP, Stoffels G, Langen KJ, Brandts C, Senft C, Harter PN, Bahr O (2017) Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease. Oncology reports 38: 3291-3296 doi:10.3892/or.2017.6013
14. Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. Journal of clinical epidemiology 47: 1245-1251 doi:10.1016/0895-4356(94)90129-5
15. Christians A, Hartmann C, Benner A, Meyer J, von Deimling A, Weller M, Wick W, Weiler M (2012) Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma. PloS one 7: e33449-e33449 doi:10.1371/journal.pone.0033449
16. Highley JR, Esiri MM, McDonald B, Cortina-Borja M, Herron BM, Crow TJ (1999) The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain 122: 99-110 doi:10.1093/brain/122.1.99 %J Brain
17. Wach J, Hamed M, Schuss P, Güresir E, Herrlinger U, Vatter H, Schneider M (2020) Impact of initial midline shift in glioblastoma on survival. Neurosurgical review doi:10.1007/s10143-020-01328-w
18. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 28: 1963-1972 doi:10.1200/jco.2009.26.3541
19. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. New England Journal of Medicine 352: 987-996 doi:doi:10.1056/NEJMoa043330
20. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G (2007) Long-term survival with glioblastoma multiforme. Brain 130: 2596-2606 doi:10.1093/brain/awm204
21. Hartmann C, Hentschel B, Simon M, Westphal M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Pietsch T, von Deimling A, Weller M (2013) Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 19: 5146-5157 doi:10.1158/1078-0432.Ccr-13-0017
22. Bjorland LS, Fluge O, Gilje B, Mahesparan R, Farbu E (2021) Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway. BMJ open 11: e043208 doi:10.1136/bmjopen-2020-043208
23. Bruhn H, Strandéus M, Milos P, Hallbeck M, Vrethem M, Lind J (2018) Improved survival of Swedish glioblastoma patients treated according to Stupp. 138: 332-337 doi:10.1111/ane.12966
24. Hansen S, Rasmussen BK, Laursen RJ, Kosteljanetz M, Schultz H, Norgard BM, Guldberg R, Gradel KO (2018) Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009-2014. Journal of neuro-oncology doi:10.1007/s11060-018-2892-7
25. Lwin Z, MacFadden D, AL-Zahrani A, Atenafu E, Miller B, Menard C, Laperriere N, Mason WP (2011) A population-based study of glioblastoma multiforme (GBM) in the new stupp paradigm: Have we improved outcome? Journal of Clinical Oncology 29: 2012-2012 doi:10.1200/jco.2011.29.15_suppl.2012
26. Ronning PA, Helseth E, Meling TR, Johannesen TB (2012) A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme. Neuro-oncology 14: 1178-1184 doi:10.1093/neuonc/nos153
27. Rusthoven CG, Koshy M, Sher DJ, Ney DE, Gaspar LE, Jones BL, Karam SD, Amini A, Ormond DR, Youssef AS, Kavanagh BD (2016) Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis. JAMA neurology 73: 821-828 doi:10.1001/jamaneurol.2016.0839 %J JAMA Neurology
28. Perry JR, Laperriere N, O'Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Cairncross JG, Roa W, Osoba D, Rossiter JP, Sahgal A, Hirte H, Laigle-Donadey F, Franceschi E, Chinot O, Golfinopoulos V, Fariselli L, Wick A, Feuvret L, Back M, Tills M, Winch C, Baumert BG, Wick W, Ding K, Mason WP (2017) Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma. N Engl J Med 376: 1027-1037 doi:10.1056/NEJMoa1611977
29. Minniti G, De Sanctis V, Muni R, Rasio D, Lanzetta G, Bozzao A, Osti MF, Salvati M, Valeriani M, Cantore GP, Maurizi Enrici R (2009) Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. Journal of neuro-oncology 91: 95-100 doi:10.1007/s11060-008-9689-z
30. Poon MTC, Sudlow CLM, Figueroa JD, Brennan PM (2020) Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis. Scientific reports 10: 11622 doi:10.1038/s41598-020-68011-4